Who
Steven Nichtberger
President & CEO
Company insider
Files Form 4 as: President & CEO, Cabaletta Bio; President and CEO, Tengion.
In numbers
- Trades disclosed
- 38
- Buys
- 3
- Sells
- 0
- Bought
- $352K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 14 Apr 2010
- Last trade
- 2 Mar 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —674,000 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —674,000 at $0.00 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $101K45,000 at $2.24 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $101K45,000 at $2.24 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —99,714 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —99,714 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —300,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —333,500 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —333,500 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —380,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —380,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —411,600 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —411,600 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —353,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —353,000 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 1 Mar 2024filed 4 Mar 2024 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —353,000 at $0.00 | filing |
| 18 Jan 2023filed 27 Jan 2023 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —411,600 at $0.00 | filing |
| 19 Oct 2022filed 19 Oct 2022 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $10K8,127 at $1.25 | filing |
News
No headline names them, or the companies they trade most, lately.